SEC filing · 8-K

Halozyme Therapeutics, Inc.: Executive or director change

James Daly has been elected to the Board of Directors of Halozyme Therapeutics.

Filed September 30, 2026

Neutral news

What happened

On September 28, 2026, James Daly was elected to the Board of Directors of Halozyme Therapeutics, Inc.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Halozyme Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.